Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Dec 2025
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Paliperidon (ausschließlich 1-monats-depot), Atc N05ax13 Für Die Zeit 01.01.2024 - 31.12.2025

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Sep 2025
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient Follitropin Beta, Atc G03ga06 for the period November 1st, 2023 - October 31st, 2025

DAK Gesundheit Tender

Germany
Closing Date5 Aug 2025
Tender AmountEUR 1 (USD 1)
Germany-hamburg: Pharmaceutical Products

DAK Gesundheit Tender

Services
Others
Germany
Closing Date9 Dec 2024
Tender AmountRefer Documents 
Germany – Health And Social Work Services – Externe Mitarbeitendenberatung (eap)

DAK Gesundheit Tender

Germany
Closing Date5 Jul 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient lidocaine, ATC N01bb02 (obg) for the period 01.09.2024 - 31.08.2026

DAK Gesundheit Tender

Others
Germany
Closing Date5 Oct 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Elafibranor (obo), Atc A05ax06 Für Die Zeit 01.12.2024 - 30.11.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Sep 2025
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient Vericiguat, Atc C01dx22 for the period November 1st, 2023 - October 31st, 2025 (1004065 - Vericiguat, Atc C01dx22)

DAK Gesundheit Tender

Others
Germany
Closing Date5 Oct 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient erythropoietin (exclusively Epoetin Zeta), (obo), ATC B03xa01 for the period 01.12.2024 - 30.11.2026

DAK Gesundheit Tender

Germany
Closing Date5 Aug 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Bosutinib, Atc L01ea04 (obg) Für Die Zeit 01.10.2024 - 30.09.2026

DAK Gesundheit Tender

Germany
Closing Date5 Jul 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient capsaicin, ATC N01bx04 (obg) for the period 01.09.2024 - 31.08.2026
331-340 of 340 active Tenders